Adverse effects associated with favipiravir in patients with COVID-19 pneumonia: a retrospective study

CONCLUSION: In this study, it was determined that favipiravir may constitute an alternative for treating COVID-19 pneumonia given that its side effects are generally well tolerated and not serious.PMID:35507992 | DOI:10.1590/1516-3180.2021.0489.R1.13082021

Source: Pain Physician - May 4, 2022 Category: Anesthesiology Authors: Figen Öztürk Ergür Murat Y ıldız Melahat Uzel Şener Suna Kavurgac ı Ayperi Ozturk Source Type: research